Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank59
Year-over-Year Change
Year-over-year total asset growth rate
Percentile
P59
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.84% |
| Q3 2025 | 17.21% |
| Q2 2025 | -3.04% |
| Q1 2025 | -9.82% |
| Q4 2024 | -2.39% |
| Q3 2024 | -5.76% |
| Q2 2024 | 88.57% |
| Q1 2024 | -1.97% |
| Q4 2023 | 11.30% |
| Q3 2023 | -5.04% |
| Q2 2023 | -12.35% |
| Q1 2023 | -12.31% |
| Q4 2022 | -5.69% |
| Q3 2022 | 39.42% |
| Q2 2022 | -9.87% |
| Q1 2022 | 1.78% |
| Q4 2021 | 1.67% |
| Q3 2021 | 46.65% |
| Q2 2021 | -2.21% |
| Q1 2021 | 8.10% |
| Q4 2020 | 12.59% |
| Q3 2020 | 103.92% |
| Q2 2020 | -9.39% |
| Q1 2020 | -11.47% |
| Q4 2019 | 54.66% |
| Q3 2019 | -5.46% |
| Q2 2019 | -0.20% |
| Q1 2019 | -5.95% |
| Q4 2018 | -8.29% |
| Q3 2018 | -6.86% |
| Q2 2018 | -11.68% |
| Q1 2018 | -5.05% |
| Q4 2017 | -9.65% |
| Q3 2017 | -4.20% |
| Q2 2017 | 28.36% |
| Q1 2017 | 55.97% |
| Q4 2016 | 7.57% |
| Q3 2016 | 48.99% |
| Q2 2016 | -6.23% |
| Q1 2016 | -1.75% |